Insider Transactions in Q4 2025 at Soleno Therapeutics Inc (SLNO)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2025
|
Kristen Yen |
SELL
Payment of exercise price or tax liability
|
Direct |
904
-3.21%
|
$44,296
$49.95 P/Share
|
|
Dec 15
2025
|
Patricia C Hirano |
SELL
Payment of exercise price or tax liability
|
Direct |
904
-6.85%
|
$44,296
$49.95 P/Share
|
|
Dec 15
2025
|
Michael F. Huang Sr. VP of Clinical Development |
SELL
Payment of exercise price or tax liability
|
Direct |
812
-2.21%
|
$39,788
$49.95 P/Share
|
|
Dec 15
2025
|
James H Mackaness CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,013
-1.91%
|
$98,637
$49.95 P/Share
|
|
Dec 15
2025
|
Meredith Manning Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,922
-4.24%
|
$94,178
$49.95 P/Share
|
|
Dec 15
2025
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Direct |
100,000
-17.56%
|
-
|
|
Dec 15
2025
|
Bhatnagar Anish CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,620
-1.32%
|
$373,380
$49.95 P/Share
|
|
Nov 17
2025
|
Kevin Norrett Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,286
+50.0%
|
-
|
|
Nov 10
2025
|
Manher Joshi Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,071
+50.0%
|
-
|
|
Oct 13
2025
|
Mark W Hahn |
BUY
Grant, award, or other acquisition
|
Direct |
10,046
+50.0%
|
-
|